Read Research Alzheimer's More http://fuckalzheimers.com/2016/09/01/antibody-reduces-harmful-brain-amyloid-plaques-in-alzheimers-patients/' title='Share this by email.' class='social email'>           

Antibody reduces harmful brain amyloid plaques in Alzheimer's patients

Aducanumab, an antibody developed by the University of Zurich, has been shown to trigger a meaningful reduction of harmful beta-amyloid plaques in patients with early-stage Alzheimer’s disease. Read & Research Alzheimer’s More

Leave a Reply